Bulletin
Investor Alert

New York Markets Close in:

NeuBase Therapeutics Inc.

NAS: NBSE

GO
/marketstate/country/us

Market open

 --Real time quotes

Dec 2, 2021, 12:11 p.m.

/zigman2/quotes/206101919/composite

$

2.78

Change

+0.02 +0.72%

Volume

Volume 56,060

Real time quotes

/zigman2/quotes/206101919/composite

Previous close

$ 2.76

$ 2.78

Change

+0.02 +0.72%

Day low

Day high

$2.66

$2.90

Open

52 week low

52 week high

$2.66

$12.89

Open

Samuel I. Backenroth

Transactions

Date Shares Transaction Value
04/30/2020 1,000   Acquisition at $6 per share. 6,000
04/10/2017 71,429   Acquisition at $0.7 per share. 50,000

Officers and Executives

Dr. Dietrich A. Stephan
Chairman, President, CEO & Chief Financial Officer
Dr. William R. Mann
Chief Operating Officer
Mr. Robert Friedlander
Chief Medical Officer
Dr. Curt W. Bradshaw
Chief Scientific Officer
Dr. Sandra Porcile Rojas-Caro
Chief Medical Officer
Dr. Anthony Rossomando
Chief Technology Officer
Ms. Shannon McCarthy
Chief People Officer
Dr. Dov A. Goldstein
Independent Director
Dr. Franklyn G. Prendergast
Independent Director
Mr. Eric I. Richman
Independent Director
Mr. Gerald J. McDougall
Independent Director
Trending Tickers
  • /zigman2/quotes/200467500/composite NVDA+6.20%
  • /zigman2/quotes/201948298/composite BABA-5.69%
  • /zigman2/quotes/202092269/composite ENSC+36.10%
  • /zigman2/quotes/200164174/composite SNOA+74.50%
  • /zigman2/quotes/207683784/composite TIGR-10.38%
X
Powered by StockTwits
Link to MarketWatch's Slice.